Pallasch and colleagues demonstrated that antagonistic anti-CD200 antibody could promote chronic lymphocytic leukemia cell-induced proliferation of antigen-specific T cells and reduce the proportion of CD4+CD25highFoxP3+ cells [38]. This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.